Drugs / Bacille Calmette-Guérin
Bacille Calmette-Guérin
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT01989026 Comparator | Oct 2013 → Oct 2017 | — | Bandim Health Project | Terminated | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bacille Calmette-Guérin | “Receiving Bacille Calmette-Guérin (BCG)-Denmark vaccine at birth has been associated with ~40% reductions in all-cause neonatal mortality.” PMID 32978212 ↗ Sep 2020 |
| Known as | BCG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01989026 ↗ |
| Known as | BCG-Denmark | “Receiving Bacille Calmette-Guérin (BCG)-Denmark vaccine at birth has been associated with ~40% reductions in all-cause neonatal mortality.” PMID 32978212 ↗ Sep 2020 |
| Modality | Vaccine | “BCG vaccine” NCT01989026 ↗ |